Noom Weight-loss
Medication Programs & Pricing
Explore Noom GLP-1 and prescription weight-loss programs *
1:1 Coaching
Transparent cost and eligibility details
Clinical care
Full access to Noom’s science-backed program
Microdose GLP-1Rx Program
Lose up to 17 pounds in 60 days*
Low-dose GLP-1 designed to reduce observable side effects
All-inclusive pricing: clinical care, medication, and digital program included
No insurance required
*Weight loss represents the top 25th percentile of self-reported data from 1,185 Noom Med users prescribed compounded GLP-1s. Average weight loss was 13 pounds.
GLP-1Rx Program
Lose up to 33 pounds in 6 months*
GLP-1 to support weight loss
All-inclusive pricing: clinical care, medication, and digital program included
No insurance required
*Weight loss represents the top 25th percentile of self-reported data from 1,597 Noom Med users prescribed compounded GLP-1s. Average weight loss was 25 pounds.
GLP-1Rx Plus Program
Noom’s most powerful weight loss program yet
Activates both GLP-1 and GIP receptors
All-inclusive pricing: clinical care, medication, and digital program included
No insurance required
Proactive Health GLP-1Rx Program
Microdose GLP-1 designed to provide health benefits
At home testing of 17 key health biomarkers
All-inclusive pricing: clinical care, medication, and digital program included
No insurance required
*Based on an analysis of self-reported data from 1,185 engaged Noom GLP-1Rx Program users.
Weight Loss Pill (Metformin)
Lose 7% or more body weight*
An oral weight loss pill + Noom’s program
All-inclusive pricing: clinical care, medication, and digital program included
No insurance required
*Based on a retrospective cohort study of patients taking metformin for 12 months along with lifestyle interventions. Metformin is not FDA-approved for weight loss.
GLP-1Rx Program Telehealth for Branded Med
Lose 37% more weight with Noom habits*
Branded prescription, pickup or pharmacy-delivered
Including clinical care, prescription and digital program.
No insurance required
*Results based on a January 2026 analysis of 14,203 Noom GLP-1Rx Program members who actively logged weight over a 40-week period. High and low engagement groupings measured by quantile of app opens. Higher app engagement was associated with greater weight loss at 16 weeks; this association does not imply causation.
37%
More Weight Loss with Noom Habits
More Weight Loss with Noom Habits
Building healthy habits with Noom may help you lose 37% more weight while on a GLP-1.**
**Based on a January 2026 analysis of 14,203 Noom GLP-1Rx Program members who actively logged their weight over a 40-week period. Engagement groups (high vs. low) were defined by quantile of app opens. Higher app engagement was associated with greater weight loss; this association does not imply causation.
Real People. Real Progress
Real People. Real Progress
Verified Noom User
The Foundation Behind Every Noom Prescription
Noom’s science-backed program helps people build healthier habits so results last beyond medication.
Learn healthier habits through short, science-backed lessons designed to support lasting change.
Get guidance, accountability, and encouragement to help you stay on track.
Customized plans with food logging, water tracking, and movement options for all fitness levels.
Designed to help you build habits and create lasting change.
FAQ
Reach your weight-loss goals and start living your healthiest life
Reach your
weight-loss goals
and start living your
healthiest life
Noom Rx Program involves healthy diet, exercise and support. Individual results vary. Meds & personalization based on clinical need. Not reviewed by FDA for safety, efficacy, or quality. No affiliation with Novo Nordisk Inc., the only US source of FDA-approved semaglutide. Not available in all 50 US states.
* Noom Med program subscription includes telehealth services and access to Noom app educational, diet, exercise and support resources. Costs of medications may not be included depending on plan selection. Medications only available when clinically indicated. Individual results vary. Compounded medications, if prescribed, are not reviewed by FDA for safety, efficacy or quality. No affiliation with Novo Nordisk, Inc., the only US source of FDA-approved semaglutide. No affiliation with Eli Lilly and Company, the only US source of FDA-approved tirzepatide. Not available in all 50 states.
